Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics

Pharmacology Biochemistry and Behavior

Volumn 97, Issue 2, 2010, Pages 205-212

  Banks, Matthew L ^a   Folk, John E ^b   Rice, Kenner C ^b   Negus, S Stevens ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Antinociception; Delta opioid receptor; Interaction; Mu opioid receptor; NMDA receptor; Rhesus monkey

Indexed keywords

4 [ALPHA[2,5 DIMETHYL 4 (2 PROPENYL) 1 PIPERAZINYL] (3 PHENYL)METHYL] N,N DIETHYLBENZAMIDE; DELTA OPIATE RECEPTOR AGONIST; FENTANYL; KETAMINE; KETAVED; MU OPIATE RECEPTOR; SNC 162; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG POTENCY; DRUG POTENTIATION; LATENT PERIOD; MALE; MONOTHERAPY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; THERMAL STIMULATION;

ANALGESICS, OPIOID; ANESTHETICS, DISSOCIATIVE; ANIMALS; BENZAMIDES; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FENTANYL; HOT TEMPERATURE; KETAMINE; MACACA MULATTA; MALE; PIPERAZINES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU; REINFORCEMENT SCHEDULE;

MACACA MULATTA;

EID: 77957800519     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2010.07.019     Document Type: Article

References (43)

1. Adams J.U., Tallarida R.J., Geller E.B., Adler M.W. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used. J Pharmacol Exp Ther 1993, 266:1261-1267.
2. Allen R.M., Granger A.L., Dykstra L.A. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta -opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther 2002, 300:435-441.
3. Baker A.K., Hoffmann V.L.H., Meert T.F. Dextromethorphan and ketamine potentiate the antinociceptive effects of [mu]- but not [delta]- or [kappa]-opioid agonists in a mouse model of acute pain. Pharmacol Biochem Behav 2002, 74:73-86.
4. Bell R.F., Eccleston C., Kalso E. Ketamine as adjuvant to opioids for cancer pain. a qualitative systematic review. J Pain Symptom Manag 2003, 26:867-875.
5. Brandt M.R., Furness M.S., Mello N.K., Rice K.C., Negus S.S. Antinociceptive effects of {delta}-opioid agonists in rhesus monkeys: effects on chemically induced thermal hypersensitivity. J Pharmacol Exp Ther 2001, 296:939-946.
6. Brown D.G., Krupp J.J. N-methyl-D-aspartate receptor (NMDA) antagonists as potential pain therapeutics. Curr Top Med Chem 2006, 6:749-770.
7. Butelman E.R., Ball J.W., Harris T.J., Kreek M.J. Topical capsaicin-induced allodynia in unanesthetized primates: pharmacological modulation. J Pharmacol Exp Ther 2003, 306:1106-1114.
8. Carstensen M., Moller A.M. Adding ketamine to morphine for intravenous patient-controlled analgesia for acute postoperative pain: a qualitative review of randomized trials. Br J Anaesth 2010, 104:401-406.
9. Dambisya Y.M., Lee T.L. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test. Meth Find Exp Clin Pharmacol 1994, 16:179-184.
10. Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen Pharmacol Vasc Syst 1997, 28:633-638.
11. Do Carmo G.P., Polt R., Bilsky E.J., Rice K.C., Negus S.S. Behavioral pharmacology of the mu/delta opioid glycopeptide MMP2200 in rhesus monkeys. J Pharmacol Exp Ther 2008, 326:939-948.
12. Dykstra L.A., Woods J.H. A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. J Pharmacol Meth 1986, 15:263-269.
13. France C.P., Snyder A.M., Woods J.H. Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J Pharmacol Exp Ther 1989, 250:197-201.
14. Furst S. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999, 48:129-141.
15. Gatch M.B., Negus S.S., Mello N.K. Antinociceptive effects of monoamine reuptake inhibitors administered alone or in combination with mu opioid agonists in rhesus monkeys. Psychopharmacology 1998, 135:99-106.
16. Heyman J.S., Jiang Q., Rothman R.B., Mosberg H.I., Porreca F. Modulation of [mu]-mediated antinociception by [delta] agonists: characterization with antagonists. Eur J Pharmacol 1989, 169:43-52.
17. Heyman J.S., Mulvaney S.A., Mosberg H.I., Porreca F. Opioid [delta]-receptor involvement in supraspinal and spinal antinociception in mice. Brain Res 1987, 420:100-108.
18. Hoffmann V.L.H., Vermeyen K.M., Adriaensen H.F., Meert T.F. Effects of NMDA receptor antagonists on opioid-induced respiratory depression and acute antinociception in rats. Pharmacol Biochem Behav 2003, 74:933-941.
19. Holtman J.R., Crooks P.A., Johnson-Hardy J., Wala E.P. Interaction between morphine and norketamine enantiomers in rodent models of nociception. Pharmacol Biochem Behav 2008, 90:769-777.
20. Jutkiewicz E.M., Eller E.B., Folk J.E., Rice K.C., Traynor J.R., Woods J.H. Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-Desoxy (SNC162) derivatives in Sprague-Dawley rats. J Pharmacol Exp Ther 2004, 309:173-181.
21. Kalb R.G., Fox A.J. Synchronized overproduction of AMPA, kainate, and NMDA glutamate receptors during human spinal cord development. J Comp Neurol 1997, 384:200-210.
22. Kenakin TP. Pharmacologic Analysis of Drug-Receptor Interaction. Raven Press, New York.
23. Kollender Y., Bickels J., Stocki D., Maruoani N., Chazan S., Nirkin A., et al. Subanaesthetic ketamine spares postoperative morphine and controls pain better than standard morphine does alone in orthopaedic-oncological patients. Eur J Cancer 2008, 44:954-962.
24. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res Rev 1999, 30:289-304.
25. Mugnaini M., van Amsterdam F.T., Ratti E., Trist D.G., Bowery N.G. Regionally differentN-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain. Br J Pharmacol 1996, 119:819-828.
26. Nadeson R., Tucker A., Bajunaki E., Goodchild C.S. Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems. Br J Anaesth 2002, 88:685-691.
27. Negus S.S., Bear A.E., Folk J.E., Rice K.C. Role of delta opioid efficacy as a determinant of mu/delta opioid interactions in rhesus monkeys. Eur J Pharmacol 2009, 602:92-100.
28. Negus S.S., Burke T.F., Medzihradsky F., Woods J.H. Effects of opioid agonists selective for mu, kappa and delta opioid receptors on schedule-controlled responding in rhesus monkeys: antagonism by quadazocine. J Pharmacol Exp Ther 1993, 267:896-903.
29. Negus S.S., Gatch M.B., Mello N.K., Zhang X., Rice K. Behavioral effects of the delta-selective opioid agonist SNC80 and related compounds in rhesus monkeys. J Pharmacol Exp Ther 1998, 286:362-375.
30. Negus S.S., Schrode K., Stevenson G.W. Mu/kappa opioid interactions in rhesus monkeys: implications for analgesia and abuse liability. Exp Clin Psychopharmacol 2008, 16:386-399.
31. O'Neill S.J., Collins M.A., Pettit H.O., McNutt R.W., Chang K.-J. Antagonistic modulation between the delta opioid agonist BW373U86 and the mu opioid agonist fentanyl in mice. J Pharmacol Exp Ther 1997, 282:271-277.
32. Pelisser T., Laurido C., Kramer N., Hernandez A., Paeile C. Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats. Eur J Pharmacol 2003, 477:23-28.
33. Roth J.E., Murray T.F., Franklin P.H. Regional distribution and characterization of [3H]dextrorphan binding sites in rat brain determined by quantitative autoradiography. J Pharmacol Exp Ther 1996, 277:1823-1836.
34. Schulte H., Graven-Nielsen T., Sollevi A., Jansson Y., Arendt-Nielsen L., Segerdahl M. Pharmacological modulation of experimental phasic and tonic muscle pain by morphine, alfentanil and ketamine in healthy volunteers. Acta Anaesthesiol Scand 2003, 47:1020-1030.
35. Schulte Hn., Sollevi A., Segerdahl Mr. The synergistic effect of combined treatment with systemic ketamine and morphine on experimentally induced windup-like pain in humans. Anesth Analg 2004, 98:1574-1580.
36. Stevenson G.W., Folk J.E., Linsenmayer D.C., Rice K.C., Negus S.S. Opioid interactions in rhesus monkeys: effects of delta + micro and delta + kappa agonists on schedule-controlled responding and thermal nociception. J Pharmacol Exp Ther 2003, 307:1054-1064.
37. Stevenson G.W., Folk J.E., Rice K.C., Negus S.S. Interactions between delta and mu opioid agonists in assays of schedule-controlled responding, thermal nociception, drug self-administration, and drug versus food choice in rhesus monkeys: studies with SNC80 [(+)-4-[(alpha±R)-alpha±-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and heroin. J Pharmacol Exp Ther 2005, 314:221-231.
38. Stewart P.E., Hammond D.L. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin. J Pharmacol Exp Ther 1993, 266:820-828.
39. Subramaniam K., Subramaniam B., Steinbrook R.A. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 2004, 99:482-495.
40. Tallarida R.J. Drug synergism and dose-effect data analysis 2000, Chapman and Hall/CRC, Boca Raton, FL.
41. Tallarida R.J. Interactions between drugs and occupied receptors. Pharmacol Ther 2007, 113:197-209.
42. Tucker A., Kim Y., Nadeson R., Goodchild C. Investigation of the potentiation of the analgesic effects of fentanyl by ketamine in humans: a double-blinded, randomised, placebo controlled, crossover study of experimental pain[ISRCTN83088383]. BMC Anesthesiol 2005, 5:2.
43. Wessinger W.D. Approaches to the study of drug interactions in behavioral pharmacology. Neurosci Biobehav Rev 1986, 10:103-113.